KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Gains from Investment Securities (2016 - 2026)

Bristol Myers Squibb has reported Gains from Investment Securities over the past 17 years, most recently at -$21.0 million for Q1 2026.

  • Quarterly Gains from Investment Securities fell 320.0% to -$21.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $590.0 million through Mar 2026, up 11900.0% year-over-year, with the annual reading at $351.0 million for FY2025, N/A changed from the prior year.
  • Gains from Investment Securities was -$21.0 million for Q1 2026 at Bristol Myers Squibb, down from $275.0 million in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $336.0 million in Q2 2025 and troughed at -$269.0 million in Q3 2023.
  • The 5-year median for Gains from Investment Securities is -$5.0 million (2025), against an average of $23.8 million.
  • Year-over-year, Gains from Investment Securities surged 690.91% in 2023 and then crashed 475.0% in 2024.
  • A 5-year view of Gains from Investment Securities shows it stood at -$44.0 million in 2022, then surged by 690.91% to $260.0 million in 2023, then tumbled by 108.85% to -$23.0 million in 2024, then skyrocketed by 1295.65% to $275.0 million in 2025, then crashed by 107.64% to -$21.0 million in 2026.
  • Per Business Quant, the three most recent readings for BMY's Gains from Investment Securities are -$21.0 million (Q1 2026), $275.0 million (Q4 2025), and $336.0 million (Q2 2025).